Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.47 USD | +14.88% | +7.86% | -39.46% |
May. 15 | Transcript : Aspira Women's Health Inc., Q1 2024 Earnings Call, May 15, 2024 | |
May. 15 | Earnings Flash (AWH) ASPIRA WOMEN'S HEALTH Reports Q1 Revenue $2.2M, vs. Street Est of $2.6M | MT |
Financials (USD)
Sales 2024 * | 10.89M | Sales 2025 * | 20.9M | Capitalization | 30.5M |
---|---|---|---|---|---|
Net income 2024 * | -17M | Net income 2025 * | -15M | EV / Sales 2024 * | 2.8 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.46 x |
P/E ratio 2024 * |
-1.9
x | P/E ratio 2025 * |
-2.41
x | Employees | 64 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 61.49% |
Latest transcript on Aspira Women's Health Inc.
1 day | +14.88% | ||
1 week | +7.86% | ||
1 month | -23.29% | ||
3 months | -37.47% | ||
6 months | -22.33% | ||
Current year | -39.46% |
Managers | Title | Age | Since |
---|---|---|---|
Nicole Sandford
CEO | Chief Executive Officer | 54 | 21-02-21 |
Sandra Milligan
PSD | President | 60 | Mar. 31 |
Torsten Hombeck
DFI | Director of Finance/CFO | 54 | 23-06-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ellen Vos
BRD | Director/Board Member | 68 | 23-05-08 |
Director/Board Member | 58 | 23-05-08 | |
Jannie Herchuk
CHM | Chairman | 61 | 23-05-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 2.47 | +14.88% | 66,243 |
24-05-30 | 2.15 | -0.46% | 30,990 |
24-05-29 | 2.16 | -2.70% | 36,028 |
24-05-28 | 2.22 | -3.06% | 57,364 |
24-05-24 | 2.29 | -1.72% | 64,244 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.46% | 30.5M | |
-38.56% | 8.39B | |
+0.18% | 3.32B | |
+9.29% | 2.49B | |
-18.21% | 2.06B | |
-24.57% | 1.59B | |
+32.37% | 1.15B | |
-7.64% | 704M | |
+8.42% | 678M | |
-29.59% | 508M |
- Stock Market
- Equities
- AWH Stock